CARv3-TEAM-E T Cells in Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioblastoma · Malignant Glioma · Recurrent Glioblastoma · Recurrent Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Contact: Study coordinator (William Curry, MD) · carteamingbm@mgb.org · 617-724-6226

Study leads

William Curry, MD
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Astrocytoma · Glioma · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

Glioma · Glioma Tumor Recurrence · Glioma, Recurrent High Grade

Abroad (travel likely)RecruitingPHASE1

Beijing, China